Europe Digital Therapeutics Market Size, Share, Comprehensive Analysis, Opportunity Assessment by 2030
The Europe Digital Therapeutics Market is projected to grow significantly, reaching US$ 1,338.13 million by 2028, up from US$ 1,023.59 million in 2021, with an impressive compound annual growth rate (CAGR) of 22.9% from 2021 to 2028.
This rapid growth is driven by increasing partnerships and
collaborations among healthcare companies, as well as the growing number of
start-ups across Europe. Digital therapeutics have been widely accepted by
employers and insurance providers due to the numerous benefits they offer. The
market has seen numerous collaborations that have contributed to its expansion.
For example, in June 2018, Cigna partnered with Omada Health to offer Cigna
health plan customers no-cost access to Omada’s digital behavioral counseling
platform as part of a preventive health improvement program. In 2019, Propeller
Health partnered with Orion Corporation to connect Orion’s Easyhaler line of
inhalers for asthma and COPD patients to Propeller’s digital platform, which
now covers over 90% of inhalable medicines for these conditions. These
strategic partnerships have played a crucial role in boosting the digital
therapeutics market in Europe.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐
๐๐๐
๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ -
https://www.businessmarketinsights.com/sample/TIPRE00028819
While the market is primarily made up of smaller players,
larger companies have shown increasing interest in the sector in recent years.
In addition, in May 2018, the Digital Therapeutics Alliance (DTA) partnered
with the United States Pharmacopeia (USP) to create standards and guidelines
for digital therapeutics. DTA further expanded its presence in Europe by
joining S3 Connected Health in October 2018, a company specializing in digital
health solutions.
Digital therapeutics are used to monitor and manage a range
of chronic conditions, such as diabetes, heart disease, and respiratory
infections. The market's growth is also supported by government initiatives,
including reimbursements, approvals, and the increasing number of patients
being monitored through digital platforms. These efforts are expected to
encourage more startups to enter the digital therapeutics industry, further
accelerating market expansion. However, the sector does face challenges, notably
related to cyber threats and data security risks, which could potentially
hinder growth.
In summary, while the European digital therapeutics market
is thriving due to strategic partnerships, government support, and increasing
interest from both small and large players, challenges surrounding data
security remain a critical consideration for future growth.
Business Market
Insights is a market research platform that provides subscription service for
industry and company reports. Our research team has extensive professional
expertise in domains such as Electronics & Semiconductor; Aerospace &
Dรฉfense; Automotive & Transportation; Energy & Power; Healthcare;
Manufacturing & Construction; Food & Beverages; Chemicals &
Materials; and Technology, Media, & Telecommunications
Akshay
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment